Zobrazeno 1 - 10
of 92
pro vyhledávání: '"Luciana, Vinti"'
Autor:
Daniela Cesana, Maria Pia Cicalese, Andrea Calabria, Pietro Merli, Roberta Caruso, Monica Volpin, Laura Rudilosso, Maddalena Migliavacca, Federica Barzaghi, Claudia Fossati, Francesco Gazzo, Simone Pizzi, Andrea Ciolfi, Alessandro Bruselles, Francesca Tucci, Giulio Spinozzi, Giulia Pais, Fabrizio Benedicenti, Matteo Barcella, Ivan Merelli, Pierangela Gallina, Stefania Giannelli, Francesca Dionisio, Serena Scala, Miriam Casiraghi, Luisa Strocchio, Luciana Vinti, Lucia Pacillo, Eleonora Draghi, Marcella Cesana, Sara Riccardo, Chiara Colantuono, Emmanuelle Six, Marina Cavazzana, Filippo Carlucci, Manfred Schmidt, Caterina Cancrini, Fabio Ciceri, Luca Vago, Davide Cacchiarelli, Bernhard Gentner, Luigi Naldini, Marco Tartaglia, Eugenio Montini, Franco Locatelli, Alessandro Aiuti
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-18 (2024)
Abstract Hematopoietic stem cell gene therapy (GT) using a γ-retroviral vector (γ-RV) is an effective treatment for Severe Combined Immunodeficiency due to Adenosine Deaminase deficiency. Here, we describe a case of GT-related T-cell acute lymphobl
Externí odkaz:
https://doaj.org/article/319bd86d084c40b6be16ee73e0b5af1a
Autor:
Naveen Pemmaraju, Branko Cuglievan, Joseph Lasky, Albert Kheradpour, Nobuko Hijiya, Anthony S. Stein, Soheil Meshinchi, Craig A. Mullen, Emanuele Angelucci, Luciana Vinti, Tariq I. Mughal, Anna B. Pawlowska
Publikováno v:
eJHaem, Vol 5, Iss 1, Pp 61-69 (2024)
Abstract Blastic plasmacytoid dendritic cell neoplasm (BPDCN) predominantly occurs in adults ≥60 years old; 10–20% of cases are pediatric or adolescent/young adult (AYA) patients. Tagraxofusp (TAG, Elzonris®) is the only approved treatment for B
Externí odkaz:
https://doaj.org/article/f0c19f1aedd446e39c2ceaabeb4efd0f
Autor:
Silvia Placidi, Paola Francalanci, Rachele Adorisio, Katia Girardi, Luciana Vinti, Mario Panebianco, Micol Rebonato, Antonio Amodeo, Giorgia Grutter
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 11 (2024)
Findings of eosinophilic and lymphomonocytic inflammatory infiltrates in endomyocardial biopsies (EMBs) may help in myocardial disease diagnosis identification. Eosinophilic myocarditis (EM), a rare condition, is fatal if left untreated and has rarel
Externí odkaz:
https://doaj.org/article/4abb7d5f1c524658b6d2e64437b940e1
Autor:
Luciana Vinti, Stephen Daw, Constantino Sabado Alvarez, Franca Fagioli, Auke Beishuizen, Gerard Michel, Maria Luisa Moleti, Michaela Cepelova, Anne Thorwarth, Charlotte Rigaud, Diego Plaza Lopez de Sabando, Judith Landman-Parker, Juan Shen, Pallavi Pillai, Patricia Marinello, Christine Mauz-Koerholz
Publikováno v:
HemaSphere, Vol 7, p e3506076 (2023)
Externí odkaz:
https://doaj.org/article/755e5b97513042a4b9db679b8dc714b8
Autor:
Carmelo Rizzari, Anja Möricke, Maria Grazia Valsecchi, Valentino Conter, Martin Zimmermann, Daniela Silvestri, Andishe Attarbaschi, Felix Niggli, Draga Barbaric, Jan Stary, Sarah Elitzur, Gunnar Cario, Luciana Vinti, Joachim Boos, Massimo Zucchetti, Claudia Lanvers-Kaminsky, Arend von Stackelberg, Andrea Biondi, Martin Schrappe
Publikováno v:
HemaSphere, Vol 7, Iss 6, p e893 (2023)
The incidence of hypersensitivity reactions (HSRs) to PEG-asparaginase (PEG-ASNase) was evaluated in 6136 children with ALL enrolled in the AIEOP-BFM ALL 2009 study. Patients with B-cell precursor-acute lymphoblastic leukemia (BCP-ALL) were stratifie
Externí odkaz:
https://doaj.org/article/2b0123de29844cabb6a049ad6f40e6f9
Autor:
Giorgio Persano, Alessandro Crocoli, Cristina Martucci, Luciana Vinti, Giulia Cassanelli, Alessandra Stracuzzi, Antonello Cardoni, Alessandro Inserra
Publikováno v:
Frontiers in Pediatrics, Vol 10 (2023)
Burkitt's lymphoma (BL) is defined as a highly invasive B-cell lymphoma, usually characterized by an excellent prognosis, more than 90% of children and adolescents being cured with highly dose-intensive multiagent chemotherapy. Primary ovarian locali
Externí odkaz:
https://doaj.org/article/2b760121050044ac8a1bec35f67a2016
Autor:
Valli De Re, Laura Caggiari, Maurizio Mascarin, Mariangela De Zorzi, Caterina Elia, Ombretta Repetto, Lara Mussolin, Marta Pillon, Paola Muggeo, Salvatore Buffardi, Maurizio Bianchi, Alessandra Sala, Luciana Vinti, Piero Farruggia, Elena Facchini, Egesta Lopci, Emanuele S. G. d’Amore, Roberta Burnelli, with the A.I.E.O.P. Consortium
Publikováno v:
Hemato, Vol 2, Iss 2, Pp 264-280 (2021)
Several studies have examined the prognostic performance of therapeutic groups (TG) and early responses to therapy on positron emission tomography/computed tomography (PET/CT) in children and adolescents with classical Hodgkin lymphoma (cHL); less re
Externí odkaz:
https://doaj.org/article/08f4de8f6dde494d9b95fba9dda98d7a
Autor:
Luciana Vinti, Stephen Daw, Constantino Sabado Alvarez, Franca Fagioli, Auke Beishuizen, Gerard Michel, Maria Luisa Moleti, Michaela Cepelova, Anne Thorwarth, Charlotte Rigaud, Diego Plaza Lopez De Sabando, Judith Landman Parker, Ying Zhu, Pallavi Pillai, Akash Nahar, Christine Mauz-Koerholz
Publikováno v:
HemaSphere, Vol 6, Pp 41-41 (2022)
Externí odkaz:
https://doaj.org/article/f302e26d651748a5ba4c7ae6dde8b754
Autor:
Marco Ruella, Valentina Bertaina, Franco Locatelli, Antonio Camera, Biagio De Angelis, Francesca Del Bufalo, Concetta Quintarelli, Pietro Merli, Marika Guercio, Simona Manni, Iolanda Boffa, Matilde Sinibaldi, Stefano Di Cecca, Simona Caruso, Zeinab Abbaszadeh, Biancamaria Cembrola, Roselia Ciccone, Alberto Orfao, Lourdes Martin-Martin, Sara Gutierrez-Herrero, Maria Herrero-Garcia, Gianni Cazzaniga, Vittorio Nunes, Simona Songia, Paolo Marcatili, Frederikke I Marin, Luciana Vinti, Mattia Algeri
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 6 (2021)
Background Methods We evaluated the impact of a high percentage of leukemia blast contamination in patient-derived starting material (SM) on CAR T-cell drug product (DP) manufacturing. In vitro as well as in vivo models were employed to identify char
Externí odkaz:
https://doaj.org/article/fc993e58dfde4d03ab19898c5289c470
Autor:
G. A. Amos Burke, Luciana Vinti, Edita Kabickova, Auke Beishuizen, Nurdan Tacyildiz, Anne Uyttebroeck, Hyoung Jin Kang, Flavio Luisi, Véronique Minard-Colin, Birgit Burkhardt, Monelle Tamegnon, Steven Sun, Madeliene Curtis, Sanjay Deshpande, Kerri Nottage, Angela Howes, Srimathi Srinivasan, Deepa Bhojwani, Robin Norris, Mitchell Cairo
Publikováno v:
Blood advances, 7(4), 602-610. American Society of Hematology
Part 1 results of the open-label, randomized, global phase 3 SPARKLE trial supported continued assessment of ibrutinib with either modified rituximab, ifosfamide, carboplatin, and etoposide (RICE) or rituximab, vincristine, ifosfamide, carboplatin, i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e398afe86edb89e121a404f65bd64a1
http://www.scopus.com/inward/record.url?scp=85149128353&partnerID=8YFLogxK
http://www.scopus.com/inward/record.url?scp=85149128353&partnerID=8YFLogxK